https://www.azeriatherapeutics.com/wp-content/uploads/2018/11/news-image-nov-18a.jpg 430 641 raslade https://www.azeriatherapeutics.com/wp-content/uploads/2017/12/azeria-therapeutics-logo-web.png raslade2018-11-13 09:29:402018-11-13 09:34:01Azeria Therapeutics announces appointment of Dr Julian Blagg as VP Drug Discovery
Azeria Therapeutics, a newly formed drug discovery company, today announced the appointment of Dr Julian Blagg as VP Drug Discovery. Dr Blagg has over 30 years’ experience in medicinal chemistry and drug discovery; he was most recently Deputy Director and Head of Chemistry at The CRUK Cancer Therapeutics Unit at the Institute of Cancer Research.
https://www.azeriatherapeutics.com/wp-content/uploads/2018/09/news-temp.jpg 430 641 raslade https://www.azeriatherapeutics.com/wp-content/uploads/2017/12/azeria-therapeutics-logo-web.png raslade2018-09-04 08:00:142018-09-04 16:15:06Azeria Therapeutics, the world’s first pioneer factor drug discovery company, announces Series A investment from Sixth Element Capital
Azeria Therapeutics Limited, a newly formed drug discovery company, today announced that it has successfully raised £4 million in Series A fundraising from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital LLP (6EC), a UK based fund manager.